Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Better Therapeutics Inc (BTTX)

Better Therapeutics Inc (BTTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 563
  • Shares Outstanding, K 49,862
  • Annual Sales, $ 0 K
  • Annual Income, $ -39,760 K
  • 60-Month Beta 2.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BTTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.15
  • Most Recent Earnings $-0.15 on 11/09/23
  • Next Earnings Date 08/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 259.78%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0060 +66.67%
on 06/24/24
0.0326 -69.33%
on 06/27/24
+0.0002 (+2.04%)
since 06/03/24
3-Month
0.0050 +100.00%
on 04/05/24
0.0326 -69.33%
on 06/27/24
-0.0010 (-9.09%)
since 04/03/24
52-Week
0.0050 +100.00%
on 04/05/24
1.3500 -99.26%
on 07/11/23
-1.2000 (-99.17%)
since 07/03/23

Most Recent Stories

More News
Stocks Move Higher Before the Open as Investors Weigh Fed Comments, U.S. CPI Looms

September S&P 500 futures (ESU23) are up +0.10%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.13% this morning after three major U.S. benchmark indices ended the regular session higher as...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
IEP : 16.68 (+1.06%)
INTC : 31.23 (+0.51%)
QCOM : 203.81 (+1.82%)
CAVA : 94.92 (+0.35%)
FMC : 55.66 (+0.07%)
GOOGL : 185.82 (+0.31%)
AMZN : 197.59 (-1.21%)
DTG.D.DX : 36.300 (-0.93%)
BTTX : 0.0100 (-11.50%)
WDFC : 213.45 (-2.03%)
Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the...

BTTX : 0.0100 (-11.50%)
Better Therapeutics Announces $6.5MM Private Placement

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address...

BTTX : 0.0100 (-11.50%)
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address...

BTTX : 0.0100 (-11.50%)
Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the...

BTTX : 0.0100 (-11.50%)
Better Therapeutics to Participate in Two Upcoming Investor Conferences

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the...

BTTX : 0.0100 (-11.50%)
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today...

BTTX : 0.0100 (-11.50%)
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today...

BTTX : 0.0100 (-11.50%)
Better Therapeutics to Participate in BTIG Digital Health Forum

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today...

BTTX : 0.0100 (-11.50%)
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic...

BTTX : 0.0100 (-11.50%)

Business Summary

Better Therapeutics Inc. is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. Better Therapeutics Inc., formerly known as Mountain Crest Acquisition Corp II, is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 0.0150
2nd Resistance Point 0.0140
1st Resistance Point 0.0120
Last Price 0.0100
1st Support Level 0.0090
2nd Support Level 0.0080
3rd Support Level 0.0060

See More

52-Week High 1.3500
Fibonacci 61.8% 0.8362
Fibonacci 50% 0.6775
Fibonacci 38.2% 0.5188
Last Price 0.0100
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar